Biopsy Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

A biopsy is a sample of tissue taken from the body for in-depth analysis of the sample to reach an effective diagnosis of a condition, wherein conventional diagnostic methods such as x-rays and body scans do not provide any conclusive evidence. Biopsies are usually carried out to detect cancer, though their application is not restricted to it. This procedure is mostly performed by interventional radiologists, cardiologist and surgeons. Biopsy might be recommended in one of the following condition, among others:

• A mammogram shows a lump or mass, indicating the possibility of breast cancer
• A mole on the skin has changed shape recently and melanoma is possible
• A person suffers from chronic hepatitis and possibility of cirrhosis needs to be ruled out

Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/220

Global Biopsy Devices Market Outlook: Burgeoning Growth In Incidence Rate Of Cancer Fueling Demand For Preventive Tests

High incidence of cancer is one of the main factor responsible for growth of the biopsy devices market. As per statistics released by the World Health Organization (WHO), around 14 million new cases of cancer were reported worldwide in 2012, with incidence rate expected to surge by exponentially by 70% over the following two decades. Furthermore, growing geriatric population characterized by a weak immune system, across the globe and increasing consumer health awareness leading to increasing preventive screening are other factors inadvertently fueling growth of the biopsy device market. Apart from this, stringent regulations posed on the companies in terms of labelling, designing and performance issues, as well as high cost of the devices are the major restrain factors which are hampering market growth. One of the main example of this is regular inspection by the regulatory authorities, in which evaluation of the equipment, records inspection and licensure are checked.

Key Vendors of Global biopsy device Market:

Boston Scientific Carefusion, Cook Medical, C R Bard, Devicor Medical Products, Hologic, Intact Medical Corporation, Precision Biopsy, Scion Medical Technologies, Integra LifeSciences Corporation, Creganna, Focal Therapeutics, Inc, Argon Medical Devices, Inc., Becton, Dickinson and Company

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/220

Market segmentation:

On the basis of product type, the global biopsy device market is divided as follows:

Needle based biopsy devices (disposable and reusable)
Vacuum-assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) devices
Biopsy curettes
Biopsy Brushes
Biopsy Punches
Biopsy forceps
General Biopsy Forceps
Hot Biopsy Forceps
Automated biopsy devices
Biopsy Guidance Systems
Manual
Robotic

Owing to their ease of use and wide availability, needle based biopsy devices account for the largest market share and are expected to retain their dominance in the market through 2024.

On the basis of technology, the biopsy devices market is segmented as follows:

Ultrasound-guided
Mammography-guided
Magnetic resonance
CT scan
Stereotactic-guided biopsy

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.